1. Home
  2. VALN vs BLMN Comparison

VALN vs BLMN Comparison

Compare VALN & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • BLMN
  • Stock Information
  • Founded
  • VALN 2012
  • BLMN 1988
  • Country
  • VALN France
  • BLMN United States
  • Employees
  • VALN N/A
  • BLMN N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • BLMN Restaurants
  • Sector
  • VALN Health Care
  • BLMN Consumer Discretionary
  • Exchange
  • VALN Nasdaq
  • BLMN Nasdaq
  • Market Cap
  • VALN 777.9M
  • BLMN 625.3M
  • IPO Year
  • VALN 2021
  • BLMN 2012
  • Fundamental
  • Price
  • VALN $10.71
  • BLMN $7.37
  • Analyst Decision
  • VALN Strong Buy
  • BLMN Hold
  • Analyst Count
  • VALN 4
  • BLMN 9
  • Target Price
  • VALN $15.75
  • BLMN $9.25
  • AVG Volume (30 Days)
  • VALN 78.1K
  • BLMN 2.1M
  • Earning Date
  • VALN 11-06-2025
  • BLMN 11-07-2025
  • Dividend Yield
  • VALN N/A
  • BLMN 8.12%
  • EPS Growth
  • VALN N/A
  • BLMN N/A
  • EPS
  • VALN N/A
  • BLMN N/A
  • Revenue
  • VALN $230,566,060.00
  • BLMN $3,933,993,000.00
  • Revenue This Year
  • VALN $15.69
  • BLMN $1.43
  • Revenue Next Year
  • VALN $22.15
  • BLMN $1.47
  • P/E Ratio
  • VALN N/A
  • BLMN N/A
  • Revenue Growth
  • VALN 25.47
  • BLMN 2.47
  • 52 Week Low
  • VALN $3.62
  • BLMN $6.09
  • 52 Week High
  • VALN $12.25
  • BLMN $17.57
  • Technical
  • Relative Strength Index (RSI)
  • VALN 53.86
  • BLMN 51.22
  • Support Level
  • VALN $9.70
  • BLMN $6.95
  • Resistance Level
  • VALN $12.23
  • BLMN $7.56
  • Average True Range (ATR)
  • VALN 0.44
  • BLMN 0.29
  • MACD
  • VALN 0.04
  • BLMN 0.08
  • Stochastic Oscillator
  • VALN 34.78
  • BLMN 77.98

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

Share on Social Networks: